Toll Free Helpline (India): 1800 1234 070
Rest of World: +91-9810852116
Free Publication Certificate
Submit Manuscript
Journal code(s)
- E-ISSN Number: 2277-7695
- P-ISSN Number: 2349-8242
- CODEN Code: PIHNBQ
- ZDB-Number: 2663038-2
- IC Journal ID: 7725
Main Menu
Special Issue
Copyright Form
Identifier
Vol. 10, Issue 8 (2021)
Impact of Rosuvastatin in post AMI/STEMI patients
Author(s):
Valon Asani, Atilla Rexhepi, Fisnik Demiri, Halit Sejfuli and Vlora Ibrahimi Ademi
Valon Asani, Atilla Rexhepi, Fisnik Demiri, Halit Sejfuli and Vlora Ibrahimi Ademi
Abstract:
In this synchronous – primary research, we tend to monitor for 6 months the effect of Rosuvastatin in patients that have been diagnosed with AMI/STEMI. Knowing that reducing and maintaining optimal lipid status in post AMI/PCI patients it is crucial, we want mathematically to verify the effect of Rosuvastatin in these patients.
In this synchronous – primary research, we tend to monitor for 6 months the effect of Rosuvastatin in patients that have been diagnosed with AMI/STEMI. Knowing that reducing and maintaining optimal lipid status in post AMI/PCI patients it is crucial, we want mathematically to verify the effect of Rosuvastatin in these patients.
Pages: 10-16 | 528 Views 75 Downloads
How to cite this article:
Valon Asani, Atilla Rexhepi, Fisnik Demiri, Halit Sejfuli, Vlora Ibrahimi Ademi. Impact of Rosuvastatin in post AMI/STEMI patients. Pharma Innovation 2021;10(8):10-16.
Journal code(s)
- E-ISSN Number: 2277-7695
- P-ISSN Number: 2349-8242
- CODEN Code: PIHNBQ
- ZDB-Number: 2663038-2
- IC Journal ID: 7725
Main Menu
Special Issue
Copyright Form
Identifier
The Pharma Innovation Journal
